Search

everythinglearnresearchcommunity

for

Search:↓

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

A reliable method was developed to measure aristolochic acid-I in rat blood.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Valproic acid can cause mild side effects like anorexia and hair loss in some epileptic patients.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Raltegravir may cause hair loss in some patients.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Finasteride may protect brain and improve behavior in rats with liver failure.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.